The Board of Directors of Zoetis Inc. (NYSE: ZTS), formerly the animal
health business of Pfizer Inc., has declared a third-quarter dividend
payable to holders of the company’s common stock of $0.065 per share.
The dividend is to be paid on Sept. 2, 2013, to holders of record on
Aug. 1, 2013.
About Zoetis
Zoetis (zō-EH-tis) is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on a 60-year
history as the animal health business of Pfizer, Zoetis discovers,
develops, manufactures and markets veterinary vaccines and medicines,
with a focus on both farm and companion animals. The company generated
annual revenues of $4.3 billion in 2012. It has more than 9,300
employees worldwide and a local presence in approximately 70 countries,
including 29 manufacturing facilities in 11 countries. Its products
serve veterinarians, livestock producers and people who raise and care
for farm and companion animals in 120 countries.
DISCLOSURE NOTICE: This news release contains forward-looking
statements, which reflect Zoetis’ current views with respect to business
plans or prospects, future operating or financial performance, and other
future events. These statements are not guarantees of future
performance. Forward-looking statements are subject to risks and
uncertainties. If one or more of these risks or uncertainties
materialize, or if management's underlying assumptions prove to be
incorrect, actual results may differ materially from those contemplated
by a forward-looking statement. Forward-looking statements speak only as
of the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement, whether as
a result of new information, future events or otherwise. A further list
and description of risks, uncertainties and other matters can be found
in our Annual Report on Form 10-K for the fiscal year ended December 31,
2012, including in the sections thereof captioned “Forward-Looking
Information and Factors That May Affect Future Results” and “Item 1A.
Risk Factors”, and in our reports on Form 8-K. These filings and
subsequent filings are available online at www.sec.gov or on request
from Zoetis.
Zoetis Inc.
Media:
Bill Price, 1-973-443-2742 (o)
william.price@zoetis.com
or
Elinore White, 1-973-443-2835 (o)
elinore.y.white@zoetis.com
or
Investor:
Dina Fede,
1-973-443-2969 (o)
or
John O’Connor, 1-973-822-7088 (o)